HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

Recruiting now · Not applicable

Conditions studied: Postpartum, Hypertension, Hypertensive Disorder of Pregnancy

In brief

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

Key facts

Study ID

NCT07204756

Run by

University of Minnesota

People needed

400

Starts

2026-01-07

Expected to finish

2028-01-31

Last updated by the study team

2026-01-14

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Discharged after delivery at University of Minnesota Medical Center
• Enrolled into the HOPE-BP Program

You may not qualify if…

• Ongoing antihypertensive medication use at 2 weeks (time of randomization)
• Have a medical comorbidity that would not be clinically appropriate to randomize
• Patients opted out of clinical research

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.